Cargando…
MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection
Methyl-CpG binding domain 2 (MBD2) leads to the silencing of methylated genes in cancer cells and was implicated in the activation of prometastatic genes in hepatocellular carcinoma (HCC). The present study aimed to investigate the expression status of MBD2 in HCC and the correlation with surgical o...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940051/ https://www.ncbi.nlm.nih.gov/pubmed/27315121 http://dx.doi.org/10.3892/mmr.2016.5404 |